The Chinese Covid-19 vaccine will begin the final tests in Brazil | Instant News

The Governor of the state of Sao Paulo, Joao Doria displays Covid-19 vaccine produced by Chinese company Sinovac Biotech during the tests in Brazil.

Brasilia: Chinese-made vaccine against the new coronavirus has entered the final testing stage on Tuesday in Brazil, where volunteers received the first doses that officials hope will be a turning point in the global pandemic.

The vaccine, developed by a private Chinese pharmaceutical company Sinovac Biotech ETF, was the third in the world to enter phase 3 clinical trials, or large-scale human trials-the last step before regulatory approval.

“We live in a unique historical time, and so I wanted to be a part of this process,” said 27-year-old doctor, who received the first dose in the clinical hospital of são Paulo.

Her name was withheld for confidentiality.

About 9,000 medical workers in six Brazilian States will receive the vaccine, known as CoronaVac, in two doses over the next three months in the study.

The Governor of Sao Paulo, Joao Doria said Monday preliminary results are expected within 90 days.

Sinovac in conjunction with the Brazilian center for the study of public health, Institute Butantan, to the test.

If the vaccine proves safe and effective, the Institute will have the right to produce 120 million doses as part of the deal, according to officials.

Brazil is the second most affected countries in pandemic coronavirus, after the United States.

His number of victims has exceeded 80,000 on Monday, and it’s been reported 2.1 million infections.

Because the virus spreads rapidly in the South American country, he is regarded as the perfect testing ground for vaccine candidates.

Brazil also aid in the conduct of phase 3 testing another experimental vaccine developed by Oxford University and pharmaceutical company AstraZeneca.

It has a similar deal to manufacture the vaccine in the country, if he is successful in the tests are also conducted in the UK and South Africa.

Brazilian regulators of health announced Monday, they have also powers phase 1, 2 and 3 test two vaccines developed by the American company Pfizer and BioNTech, Germany.

Researchers around the world seek to develop and test a vaccine against the virus. There are more than 150 projects.

The study, published Monday in the British medical journal The Lancet found two vaccine candidates are safe and produced an immune response in phase 2 studies: Oxford vaccines and other Chinese production of the vaccine developed by pharmaceutical company, Cancino biologics and Beijing Institute of biotechnology.


image source

to request modification Contact us at Here or [email protected]